Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000030

CEO bought 160,774 shares at an average $0.01 ($1,904)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

19 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-07 Purchase : show line 1 in the form +10,000 $0.01 $124 21,602,123 D
2019-05-07 Purchase : show line 2 in the form +10,000 $0.01 $120 21,612,123 D
2019-05-08 Purchase : show line 3 in the form +10,000 $0.01 $115 21,622,123 D
2019-05-08 Purchase : show line 4 in the form +10,000 $0.01 $116 21,632,123 D
2019-05-08 Purchase : show line 5 in the form +20,000 $0.01 $238 21,652,123 D
2019-05-08 Purchase : show line 6 in the form +2,000 $0.01 $23 21,654,123 D
2019-05-08 Purchase : show line 7 in the form +2,000 $0.01 $23 21,656,123 D
2019-05-08 Purchase : show line 8 in the form +2,000 $0.01 $23 21,658,123 D
Open-market purchases · 160,774 sh · avg $0.01 · $1,904
Loading xslF345X03/primary_doc.xml…